Michael represents public and late-stage private life sciences and technology companies in a broad range of corporate matters, with an emphasis on corporate governance and SEC reporting advice at Cooley. He counsels public companies and their boards on securities regulation and governance issues, including Exchange Act reporting, annual meetings, shareholder activism, insider trading, and board structure and composition matters. Michael also advises companies on environmental, social, and governance (ESG) matters, including sustainability reporting, board oversight and disclosure controls, and shareholder and stakeholder engagement.
